MedPage Today on MSN
'Most Compelling' Data Yet for Metastasis-Directed Therapy in Prostate Cancer
But an association with improved overall survival failed to reach statistical significance ...
Oxybutynin, a common drug to manage overactive bladder, may help alleviate hot flash symptoms among men receiving androgen ...
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the immune system.
Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.
Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
Relief for men experiencing the challenges of Benign Prostatic Hyperplasia (BPH), or prostate enlargement, has arrived with the introduction of Flowel and Flowel Plus by Superior Pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results